Compare Aventis Pharma with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs STERLING BIOTECH - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA STERLING BIOTECH SANOFI INDIA/
STERLING BIOTECH
 
P/E (TTM) x 35.4 -0.4 - View Chart
P/BV x 6.2 0.0 43,517.2% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 SANOFI INDIA   STERLING BIOTECH
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
STERLING BIOTECH
Dec-13
SANOFI INDIA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs6,84011 65,143.8%   
Low Rs4,6303 136,176.5%   
Sales per share (Unadj.) Rs1,203.126.8 4,488.2%  
Earnings per share (Unadj.) Rs165.3-15.0 -1,104.9%  
Cash flow per share (Unadj.) Rs209.9-5.5 -3,841.6%  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.654.9 1,755.8%  
Shares outstanding (eoy) m23.03267.87 8.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.80.3 1,838.6%   
Avg P/E ratio x34.7-0.5 -7,468.2%  
P/CF ratio (eoy) x27.3-1.3 -2,148.0%  
Price / Book Value ratio x6.00.1 4,699.8%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0781,862 7,094.5%   
No. of employees `0003.31.4 243.8%   
Total wages/salary Rs m4,068547 744.0%   
Avg. sales/employee Rs Th8,393.85,303.3 158.3%   
Avg. wages/employee Rs Th1,232.4403.8 305.2%   
Avg. net profit/employee Rs Th1,153.0-2,959.0 -39.0%   
INCOME DATA
Net Sales Rs m27,7087,181 385.9%  
Other income Rs m89743 2,105.6%   
Total revenues Rs m28,6057,223 396.0%   
Gross profit Rs m6,235947 658.5%  
Depreciation Rs m1,0272,543 40.4%   
Interest Rs m74,377 0.2%   
Profit before tax Rs m6,098-5,931 -102.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292-1,924 -119.1%   
Profit after tax Rs m3,806-4,007 -95.0%  
Gross profit margin %22.513.2 170.6%  
Effective tax rate %37.632.4 115.8%   
Net profit margin %13.7-55.8 -24.6%  
BALANCE SHEET DATA
Current assets Rs m15,92214,335 111.1%   
Current liabilities Rs m6,23549,809 12.5%   
Net working cap to sales %35.0-494.0 -7.1%  
Current ratio x2.60.3 887.3%  
Inventory Days Days64403 15.8%  
Debtors Days Days21171 12.2%  
Net fixed assets Rs m7,53955,432 13.6%   
Share capital Rs m230268 85.9%   
"Free" reserves Rs m21,96213,935 157.6%   
Net worth Rs m22,19214,701 151.0%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m29,83973,988 40.3%  
Interest coverage x872.1-0.4 -245,701.0%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.1 956.8%   
Return on assets %12.80.5 2,551.2%  
Return on equity %17.2-27.3 -62.9%  
Return on capital %27.5-6.4 -428.1%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m7,5871,860 407.9%   
Fx outflow Rs m7,14525 28,706.3%   
Net fx Rs m4421,835 24.1%   
CASH FLOW
From Operations Rs m3,7391,719 217.5%  
From Investments Rs m-731-3,148 23.2%  
From Financial Activity Rs m-1,9721,426 -138.3%  
Net Cashflow Rs m1,036-3 -30,470.6%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.0 -  
FIIs % 14.6 9.9 147.5%  
ADR/GDR % 0.0 16.9 -  
Free float % 10.5 39.3 26.7%  
Shareholders   15,184 21,482 70.7%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare SANOFI INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 16, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS